Luis MorenoFredy RiveroNicolas Forero RamirezLuis Felipe Cabrera Vargas2026-03-222026-03-22202610.1016/j.jvsv.2026.102442https://doi.org/10.1016/j.jvsv.2026.102442https://andeanlibrary.org/handle/123456789/79228Basilic access 1470-nm EVLA of refluxing gonadal veins is feasible, safe, and shows high early technical and clinical success with same-day discharge and no complications in this pilot cohort. Larger multicenter randomized trials with follow-up beyond 12 months, blinded imaging review, standardized patient-reported outcomes, and cost-effectiveness analyses are warranted.enMedicineBasilic VeinRadiologySurgeryAblationRandomized controlled trialVeinThermal ablationProspective cohort studyMulticenter studyarticle